Anti-hepatitis c virus activity of crude extract and fractions of entada africana in genotype 1b replicon systems

American Journal of Chinese Medicine

Volumn 42, Issue 4, 2014, Pages 853-868

  Galani Tietcheu, Borris Rosnay ^a,b,c   Sass, Gabriele ^c   Njayou, Nico Frederic ^a   Mkounga, Pierre ^a   Tiegs, Gisa ^c   Moundipa, Paul Fewou ^a  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b UNIVERSITY OF NGAOUNDERE   (Cameroon)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

2 5 Oligoadenylate Synthetase 3; Entada africana; Heme Oxygenase 1; Hepatitis C Virus

Indexed keywords

ANTIVIRUS AGENT; DICHLOROMETHANE; ENTADA AFRICANA STEM BARK EXTRACT; HEME OXYGENASE 1; PLANT EXTRACT; UNCLASSIFIED DRUG; 2',5' OLIGOADENYLATE SYNTHETASE; OAS3 PROTEIN, HUMAN; ENTADA AFRICANA CRUDE EXTRACT; METHANOL;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BARK; CELL FRACTIONATION; CELL VIABILITY; CHINESE MEDICINE; CONTROLLED STUDY; DRUG EFFECT; ENTADA AFRICANA; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS SUBTYPE 1B; IC 50; IN VITRO STUDY; LIMIT OF QUANTITATION; LUCIFERASE ASSAY; MTT ASSAY; NONHUMAN; PLANT STEM; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA GENE; VIRUS REPLICATION; CELL SURVIVAL; CHEMICAL PHENOMENA; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; FABACEAE; GENETICS; GENOTYPE; HEPACIVIRUS; HUMAN; LIVER CELL; METABOLISM; PHYSIOLOGY; REPLICON; TUMOR CELL LINE; VIROLOGY; IC50; REPLICON CELL;

2',5'-OLIGOADENYLATE SYNTHETASE; CELL LINE, TUMOR; CELL SURVIVAL; DEPRESSION, CHEMICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FABACEAE; GENOTYPE; HEME OXYGENASE-1; HEPACIVIRUS; HEPATOCYTES; HUMANS; PLANT EXTRACTS; REPLICON; VIRUS REPLICATION;

EID: 84904350650     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X14500542     Document Type: Article

References (37)

1. Cainelli, F. Liver diseases in developing countries. World. J. Hepatol. 4(3): 66-67, 2012.
2. Calland, N. EGCG and Delphinidin: Two New Natural Inhibitors of Hepatitis C Virus Entry. PhD thesis, University of Lille II, France, 2012, pp. 1-202.
3. Calland, N., J. Dubuisson, Y. Rouillé and K. Séron. Hepatitis C virus and natural compounds: A new antiviral. Viruses 55(3): 2197-2217, 2012.
4. Chen, M., M. Lee, J. Chuang, Y. Li, S. Ning, J. Chen and Y. Liu. Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of Akt. Int. J. Mol. Med. 30: 1021-1028, 2012a.
5. Chen, W.C., S.Y. Wang, C.C. Chiu, C.K. Tseng, C.K. Lin, H.C. Wang and J.C. Lee. Lucidone suppresses hepatitis C virus replication by Nrf2-mediated heme oxygenase-1 induction. Antimicrob. Agents Chemother., December: 1-57, 2012b.
6. Cioffi, G., F. Dal Piaz, P. De Caprariis, R. Sanogo, S. Marzocco, G. Autore and N. De Tommasi. Antiproliferative triterpene saponins from Entada africana. J. Nat. Prod. 69(9): 1323-1329, 2006.
7. Diallo, D., B.S. Paulsen, T.H. Liljebäck and T.E. Michaelsen. Polysaccharides from the roots of Entada africana Guill. et Perr., Mimosaceae, with complement fixing activity. J. Ethno-pharmacol. 74(2): 159-171, 2001.
8. Douare, Â.I. Contribution to the Clinical Study of Entada africana in the Treatment of Viral Hepatitis. University of Bamako, Mali, 1991.
9. Ezenyi, I., C.L. Ranarivelo, S.A. Oluwakanyinsola and M. Emeje. Analgesic, anti-inflammatory, and heme biomineralization inhibitory properties of Entada africana ethanol leaf extract with antiplasmodial activity against Plasmodium falciparum. J. Basic Clin. Physiol. Pharmacol. 1-7, 2013.
10. Fabry, W., P. Okemo and R. Ansorg. Fungistatic and fungicidal activity of east African medicinal plants. Mycoses 39: 67-70, 1996.
11. Frese, M., K. Barth, A. Kaul, V. Lohmann, V.Schwarzle and R. Bartenschlager. Hepatitis C virus RNA replication is resistant to tumour necrosis factor-alpha. J. Gen. Virol. 84: 1253-1259, 2003.
12. Fried, M.W., V.J. Navarro, N. Afdhal, S.H. Belle, A.S. Wahed, R.L. Hawke and K.R. Reddy. Silymarin in NASH and C Hepatitis (SyNCH) Study Group Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: A randomized controlled trial. J. Am. Med. Assoc. 308: 274-282, 2012.
13. Kaplan, K. Low-and middle-income countries defuse hepatitis C. HIV Treat. Bull. 2013. Retrieved from http://i-base.info/htb/21506.
14. Karou, S.D., T. Tchacondo, L. Ouattara, K. Anani, A. Savadogo, A. Agbonon, M.B. Attaia, C. de Souza, M. Sakly and J. Simpore. Antimicrobial, antiplasmodial, haemolytic and antioxidant activities of crude extracts from three selected Togolese medicinal plants. Asian Pac. J. Trop. Med. 4: 808-813, 2011.
15. Lavanchy, D. Evolving epidemiology of hepatitis C virus. Clin. Microb. Infect. 17(2): 107-111, 2011.
16. Lee, J., S. Lim, S. Kang, S. Min, K. Son and H. Lee. Saponin inhibits hepatitis C virus propagation by up-regulating suppressor of Cytokine signaling 2. PloS One 7(6): 1-12, 2012.
17. Lehmann, E., W.H. El-Tantawy, M. Ocker, R. Bartenschlager, V. Lohmann, S. Hashemolhosseini, G. Tiegs and G. Sass. The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response. Hepatol. 51(2): 398-404, 2012.
18. Lohmann, V., F. Korner, J. Koch, U. Herian, L. Theilmann and R. Bartenschlager. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285(2): 110-113, 1999.
19. Maiga, A., D. Diallo, S. Fane, R. Sanogo, B.S. Paulsen and B. Cisse. A survey of toxic plants on the market in the district of Bamako, Mali: Traditional knowledge compared with a literature search of modern pharmacology and toxicology. J. Ethnopharmacol. 96: 183-193, 2005.
20. Ndjomou, J., B. Kupfer, B. Kochan, L.L. Zekeng, Kaptue and B. Matz. Hepatitis C virus infection and genotypes among human immunodeficiency virus high-risk groups in Cameroon. J. Med. Virol. 66(2): 179-186, 2002.
21. Nerrienet, E., R. Pouillot, G. Lachenal, R. Njouom, J. Mfoupouendoun, C. Bilong, P. Mauclere, C. Pasquier and A. Ayouba. Hepatitis C virus infection in cameroon: A cohort-effect. J. Med. Virol. 76(2): 208-214, 2005.
22. 4 in primary rat hepatocytes. Int. J. Pharm., Photon. 104: 306-314, 2013.
23. Njayou, N.F., P.F. Moundipa, N.A. Tchana and F. Tchouanguep. Antihepatotoxic potential of three Bamun folk medicinal plants. Cam. J. Biochem. Sci. 4: 325-330, 2004.
24. Njouom, R., M.T. Sartre, I. Timba, E. Nerrienet, P. Tchendjou, C. Pasquier and D. Rousset. Efficacy and safety of peginterferon alpha-2a/ribavirin in treatment-naive Cameroonian patients with chronic hepatitis C. J. Med. Virol. 80(12): 2079-2085, 2008.
25. Owona, A.V.B., F.N. Njayou, S. Laufer, P.F. Fewou and H. J. Schluesener. A fraction of stem bark extract of Entada africana suppresses lipopolysaccharide-induced inflammation in RAW 264.7 cells. J. Ethnopharmacol. 149(1): 162-168, 2013a.
26. 2/MEOH 5% inhibits inducible nitric oxide synthase and pro-inflammatory cytokines gene expression induced by lipopolysaccharide in microglia. BMC Compl. Altern. Med. 13(1): 254, 2013b.
27. Paracha, U.Z., K. Fatima, M. Alqahtani, A. Chaudhary, A. Abuzenadah, G. Damanhouri and I. Qadri. Oxidative stress and hepatitis C virus. Virol. J. 10(1): 251, 2013.
28. Rehman, S., U.A. Ashfaq, S. Riaz, T. Javed and S. Riazuddin. Antiviral activity of Acacia nilotica against Hepatitis C Virus in liver infected cells. Virol. J. 8(1): 220, 2011.
29. Sanogo, R., M.P. Germano, V.D. Angelo, M. Guglielmo and R. De. Pasquale. Antihepatotoxic properties of Entada africana (Mimosaceae). Phytother. Res. 12: 1997-1999, 1998.
30. Sarrazin C., Z.S. Resistance to direct antiviral agents in patients with hepatitis C virus infection. Gastroenterology 138: 447-462, 2010.
31. Sass, G., S. Seyfried, M. Parreira Soares, K. Yamashita, E. Kaczmarek, W.L. Neuhuber and G. Tiegs. Cooperative effect of biliverdin and carbon monoxide on survival of mice in immune-mediated liver injury. Hepatology 40: 1128-1135, 2004.
32. Schaefer, M. and S. Mauss. Hepatitis C treatment in patients with drug addiction: Clinical management of interferon-alpha-associated psychiatric side effects. Curr. Drug Abuse Rev. 1: 177-187, 2008.
33. Sen, G.C. and S.N. Sarkar. The interferon-stimulated genes: Targets of direct signaling by interferons, double-stranded RNA, and viruses. Springer-Verlag Berlin Heidelberg, 316: 233-250, 2007.
34. Silva, O., S. Barbosa, A. Diniz, M.L. Valdeira and E. Gomes. Plant extracts with antiviral activity against Herpes simplex virus type 1 and African swine fever virus. Int. J. Pharmacogn. 35: 12-16, 1997.
35. Wagoner, J., A. Negash, O.J. Kane, L.E. Martinez, Nahmias, Y., N. Bourne, D.M. Owen, J. Grove. C. Brimacombe, J.A. McKeating, E.I. Pecheur, T.N. Graf, N.H. Oberlies, V. Lohmann, F. Cao, J.E. Tavis and S.J. Polyak. Multiple effects of silymarin on the Hepatitis C virus lifecycle. Hepatol. 51(6): 1912-1921, 2010.
36. WHO (1996). World Health Report, Geneva, Switzerland.
37. Wu, S., C. Lin, Y. Chuang, F. Chang, C. Tseng, Y. Wu and J. Lee. Anti-hepatitis C virus activity of 3-hydroxy caruilignan C from Swietenia macrophylla stems. J. Viral Hepatitis. 19: 364-370, 2012.